Physician profile
David J Cha
NPI 1871882209
$2,749.65
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $277 · 2020: $271 · 2021: $12.09 · 2022: $508 · 2023: $132 · 2024: $1,549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Food and Beverage: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Food and Beverage | $180.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,529.58 | 2024 | |
| Glaxosmithkline, LLC. | $239.99 | 2022-2023 | Arexvy |
| Integra Lifesciences Corporation | $153.00 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $140.32 | 2019-2022 | |
| Shire North American Group INC | $120.54 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $117.99 | 2020 | |
| Veloxis Pharmaceuticals, INC. | $109.12 | 2022-2024 | Envarsus |
| Sanofi-Aventis U.S. LLC | $97.42 | 2022 | |
| Medtronic, INC. | $84.70 | 2022-2023 | Signia |
| Sanara Medtech INC. | $47.86 | 2021-2022 | |
| Lemaitre Vascular, INC. | $29.28 | 2022 | |
| Ethicon US, LLC | $26.53 | 2022 | |
| Abbvie INC. | $21.91 | 2019 | |
| Bard Peripheral Vascular, INC. | $16.79 | 2022 | |
| Heron Therapeutics, INC. | $14.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.